This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Rinat Moshkovits-Kaptsan: Innovator in Pharmaceutical Chemistry
Introduction
Rinat Moshkovits-Kaptsan is a notable inventor based in Raanana, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of treatments for HIV infection. His work has led to the creation of innovative compounds that enhance the efficacy of existing medications.
Latest Patents
Moshkovits-Kaptsan holds 1 patent for his invention titled "Raltegravir salts and crystalline forms thereof." This patent includes new salts of Raltegravir and crystalline forms, as well as pharmaceutical compositions containing these salts. The invention outlines methods for using these compounds to treat HIV infection and describes a process for preparing Raltegravir potassium.
Career Highlights
He is currently employed at Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role involves research and development aimed at creating effective treatments for various diseases, with a focus on antiviral medications.
Collaborations
Moshkovits-Kaptsan has worked alongside talented colleagues such as Lilach Hedvati and Revital Burstein. Their collaborative efforts have contributed to advancements in pharmaceutical research and development.
Conclusion
Rinat Moshkovits-Kaptsan is a dedicated inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of HIV infection significantly. His innovative approach and collaboration with skilled professionals highlight the importance of teamwork in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
